Human MicroFlora (HMF) probiotic strains are research-driven and clinically proven in randomized, double-blind, placebo-controlled human trials at 25 billion CFU per day. Proprietary non-pathogenic human sourced microflora bacterial strains are utilized as they have strong epithelial adherence and a naturally high tolerance to stomach acid.
Adults, Adolescents and Children (6 years and older): Take one capsule daily, at least two to three hours before or after taking antibiotics, or as recommended by your healthcare practitioner.
If you have an immune compromised condition, do not use. If you are experiencing nausea, fever, vomiting, bloody diarrhoea or severe abdominal pain, consult your healthcare practitioner prior to use. If symptoms of digestive upset occur, worsen or persist beyond three days, discontinue use and consult your healthcare practitioner. Guaranteed to contain no added wheat, starch, gluten, soy, artifical colouring or flavouring, antimicrobial preservatives, dairy or animal products. Ideal for vegans.
Safety-sealed for your protection and for product freshness. Do not use if outer seal is missing or broken. Store under refrigeration (below 8°C).
EACH CAPSULE CONTAINS:
Probiotic Consortium. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15 billion
CFU Lactobacillus acidophilus (CUL-60) Lactobacillus acidophilus (CUL-21) Bifidobacterium bifidum (CUL-20) Bifidobacterium animalis subsp. lactis (CUL-34) Lactobacillus salivarius (CUL-61) Lactobacillus paracasei (CUL-08) Lactobacillus plantarum (CUL-66) Lactobacillus casei (CUL-06) Lactobacillus fermentum (CUL-67) Lactobacillus gasseri (CUL-09) Bifidobacterium animalis subsp. lactis (CUL-62) Bifidobacterium breve (CUL-74) Streptococcus salivarius subsp. thermophilus (CUL-68) Lactobacillus acidophilus (NCFMTM) Bifidobacterium animalis subsp. lactis (HN019) Lactobacillus rhamnosus (HN001)
Non-Medicinal Ingredients: Hypromellose, cellulose, silica